Income Tax Expense (Benefit) of Pharma-Bio Serv, Inc. from 31 Jul 2010 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Pharma-Bio Serv, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Jul 2010 to 31 Oct 2025.
Pharma-Bio Serv, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Oct 2025 was $5,202, a 83% increase year-over-year.
Pharma-Bio Serv, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Oct 2025 was $6,203, a 72% decline year-over-year.
Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2025 was $6,203, a 72% decline from 2024.
Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2024 was $22,171, a 94% decline from 2023.
Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2023 was $377,307, a 108% increase from 2022.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

Pharma-Bio Serv, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$6,203	$5,202	+$25,758	+83%	01 Aug 2025	31 Oct 2025	10-K	29 Jan 2026	2025	FY
Q2 2025	$19,555	$4,779	-$14,225	-75%	01 May 2025	31 Jul 2025	10-Q	15 Sep 2025	2025	Q3
Q1 2025	$5,330	$5,511	-$15,668	-74%	01 Feb 2025	30 Apr 2025	10-Q	16 Jun 2025	2025	Q2
Q4 2024	$10,338	$1,115	-$11,833	-91%	01 Nov 2024	31 Jan 2025	10-Q	17 Mar 2025	2025	Q1
Q3 2024	$22,171	$30,960	-$30,273	-4407%	01 Aug 2024	31 Oct 2024	10-K	29 Jan 2026	2025	FY
Q2 2024	$52,444	$19,004	-$42,205	-69%	01 May 2024	31 Jul 2024	10-Q	15 Sep 2025	2025	Q3
Q1 2024	$94,649	$21,179	-$146,861	-87%	01 Feb 2024	30 Apr 2024	10-Q	16 Jun 2025	2025	Q2
Q4 2023	$241,510	$12,948	-$135,797	-91%	01 Nov 2023	31 Jan 2024	10-Q	17 Mar 2025	2025	Q1
Q3 2023	$377,307	$687	-$58,352	-101%	01 Aug 2023	31 Oct 2023	10-K	29 Jan 2025	2024	FY
Q2 2023	$435,659	$61,209	+$33,421	+120%	01 May 2023	31 Jul 2023	10-Q	16 Sep 2024	2024	Q3
Q1 2023	$402,238	$168,040	+$123,033	+273%	01 Feb 2023	30 Apr 2023	10-Q	14 Jun 2024	2024	Q2
Q4 2022	$279,205	$148,745	+$97,526	+190%	01 Nov 2022	31 Jan 2023	10-Q	18 Mar 2024	2024	Q1
Q3 2022	$181,679	$57,665	-$18,222	-24%	01 Aug 2022	31 Oct 2022	10-K	29 Jan 2024	2023	FY
Q2 2022	$199,901	$27,788	-$10,482	-27%	01 May 2022	31 Jul 2022	10-Q	14 Sep 2023	2023	Q3
Q1 2022	$210,383	$45,007	-$591	-1.3%	01 Feb 2022	30 Apr 2022	10-Q	14 Jun 2023	2023	Q2
Q4 2021	$210,974	$51,219	-$2,272	-4.2%	01 Nov 2021	31 Jan 2022	10-Q	17 Mar 2023	2023	Q1
Q3 2021	$213,246	$75,887	+$67,879	+848%	01 Aug 2021	31 Oct 2021	10-K	30 Jan 2023	2022	FY
Q2 2021	$145,367	$38,270	-$56,108	-59%	01 May 2021	31 Jul 2021	10-Q	14 Sep 2022	2022	Q3
Q1 2021	$201,475	$45,598	-$35,809	-44%	01 Feb 2021	30 Apr 2021	10-Q	14 Jun 2022	2022	Q2
Q4 2020	$237,284	$53,491	-$1,804	-3.3%	01 Nov 2020	31 Jan 2021	10-Q	17 Mar 2022	2022	Q1
Q3 2020	$239,088	$8,008	+$1,609	+25%	01 Aug 2020	31 Oct 2020	10-K	11 Feb 2022	2021	FY
Q2 2020	$237,479	$94,378	+$82,996	+729%	01 May 2020	31 Jul 2020	10-Q	14 Sep 2021	2021	Q3
Q1 2020	$154,483	$81,407	+$6,149	+8.2%	01 Feb 2020	30 Apr 2020	10-Q	14 Jun 2021	2021	Q2
Q4 2019	$148,334	$55,295	+$12,340	+29%	01 Nov 2019	31 Jan 2020	10-Q	17 Mar 2021	2021	Q1
Q3 2019	$135,994	$6,399	-$25,137	-80%	01 Aug 2019	31 Oct 2019	10-K	01 Feb 2021	2020	FY
Q2 2019	$161,131	$11,382	-$41,584	-79%	01 May 2019	31 Jul 2019	10-Q	14 Sep 2020	2020	Q3
Q1 2019	$202,715	$75,258	+$75,258		01 Feb 2019	30 Apr 2019	10-Q	15 Jun 2020	2020	Q2
Q4 2018	$127,457	$42,955	-$2,658,068	-98%	01 Nov 2018	31 Jan 2019	10-Q	16 Mar 2020	2020	Q1
Q3 2018	$2,785,525	$31,536	+$30,876	+4678%	01 Aug 2018	31 Oct 2018	10-K	29 Jan 2020	2019	FY
Q2 2018	$2,754,649	$52,966	+$51,616	+3823%	01 May 2018	31 Jul 2018	10-Q	16 Sep 2019	2019	Q3
Q1 2018	$2,703,033	$0	-$106		01 Feb 2018	30 Apr 2018	10-Q	14 Jun 2019	2019	Q2
Q4 2017	$2,703,139	$2,701,023	+$2,699,273	+154244%	01 Nov 2017	31 Jan 2018	10-Q	18 Mar 2019	2019	Q1
Q3 2017	$3,866	$660	-$521	-44%	01 Aug 2017	31 Oct 2017	10-K	29 Jan 2019	2018	FY
Q2 2017	$4,387	$1,350	-$11,306	-89%	01 May 2017	31 Jul 2017	10-Q	14 Sep 2018	2018	Q3
Q1 2017	$15,693	$106^*	-$7,459		01 Feb 2017	30 Apr 2017	10-Q	14 Jun 2018	2018	Q2
Q4 2016	$23,152	$1,750	-$29,682	-94%	01 Nov 2016	31 Jan 2017	10-Q	19 Mar 2018	2018	Q1
Q3 2016	$52,834	$1,181	-$54,612	-98%	01 Aug 2016	31 Oct 2016	10-K	29 Jan 2018	2017	FY
Q2 2016	$107,446	$12,656	-$28,479	-69%	01 May 2016	31 Jul 2016	10-Q	14 Sep 2017	2017	Q3
Q1 2016	$135,925	$7,565	-$24,660	-77%	01 Feb 2016	30 Apr 2016	10-Q	14 Jun 2017	2017	Q2
Q4 2015	$160,585	$31,432	-$7,397	-19%	01 Nov 2015	31 Jan 2016	10-Q	17 Mar 2017	2017	Q1
Q3 2015	$167,982	$55,793	-$52,022	-48%	01 Aug 2015	31 Oct 2015	10-K	31 Jan 2017	2016	FY
Q2 2015	$220,004	$41,135	-$59,256	-59%	01 May 2015	31 Jul 2015	10-Q	14 Sep 2016	2016	Q3
Q1 2015	$279,260	$32,225	-$58,409	-64%	01 Feb 2015	30 Apr 2015	10-Q	14 Jun 2016	2016	Q2
Q4 2014	$337,669	$38,829	-$126,858	-77%	01 Nov 2014	31 Jan 2015	10-Q	16 Mar 2016	2016	Q1
Q3 2014	$464,527	$107,815	-$176,005	-62%	01 Aug 2014	31 Oct 2014	10-K	29 Jan 2016	2015	FY
Q2 2014	$640,532	$100,391	-$187,133	-65%	01 May 2014	31 Jul 2014	10-Q	14 Sep 2015	2015	Q3
Q1 2014	$827,665	$90,634	-$270,555	-75%	01 Feb 2014	30 Apr 2014	10-Q	15 Jun 2015	2015	Q2
Q4 2013	$1,098,220	$165,687	-$71,601	-30%	01 Nov 2013	31 Jan 2014	10-Q	17 Mar 2015	2015	Q1
Q3 2013	$1,169,821	$283,820	-$32,555	-10%	01 Aug 2013	31 Oct 2013	10-K	29 Jan 2015	2014	FY
Q2 2013	$1,202,376	$287,524	-$9,649	-3.2%	01 May 2013	31 Jul 2013	10-Q	15 Sep 2014	2014	Q3
Q1 2013	$1,212,025	$361,189	+$123,269	+52%	01 Feb 2013	30 Apr 2013	10-Q	16 Jun 2014	2014	Q2
Q4 2012	$1,088,756	$237,288	+$20,150	+9.3%	01 Nov 2012	31 Jan 2013	10-Q	17 Mar 2014	2014	Q1
Q3 2012	$1,068,606	$316,375	+$107,418	+51%	01 Aug 2012	31 Oct 2012	10-K	29 Jan 2014	2013	FY
Q2 2012	$961,188	$297,173	+$625,441		01 May 2012	31 Jul 2012	10-Q	16 Sep 2013	2013	Q3
Q1 2012	$335,747	$237,920	-$21,506	-8.3%	01 Feb 2012	30 Apr 2012	10-Q	14 Jun 2013	2013	Q2
Q4 2011	$357,253	$217,138	+$52,456	+32%	01 Nov 2011	31 Jan 2012	10-Q	18 Mar 2013	2013	Q1
Q3 2011	$304,797	$208,957			01 Aug 2011	31 Oct 2011	10-K	29 Jan 2013	2012	FY
Q2 2011		$328,268	-$413,090	-487%	01 May 2011	31 Jul 2011	10-Q	14 Sep 2012	2012	Q3
Q1 2011		$259,426			01 Feb 2011	30 Apr 2011	10-Q	14 Jun 2012	2012	Q2
Q4 2010		$164,682			01 Nov 2010	31 Jan 2011	10-Q	16 Mar 2012	2012	Q1
Q2 2010		$84,822			01 May 2010	31 Jul 2010	10-Q	14 Sep 2011	2011	Q3

Pharma-Bio Serv, Inc. Annual Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$6,203	-$15,968	-72%	01 Nov 2024	31 Oct 2025	10-K	29 Jan 2026	2025	FY
2024	$22,171	-$355,136	-94%	01 Nov 2023	31 Oct 2024	10-K	29 Jan 2026	2025	FY
2023	$377,307	+$195,628	+108%	01 Nov 2022	31 Oct 2023	10-K	29 Jan 2025	2024	FY
2022	$181,679	-$31,567	-15%	01 Nov 2021	31 Oct 2022	10-K	29 Jan 2024	2023	FY
2021	$213,246	-$25,842	-11%	01 Nov 2020	31 Oct 2021	10-K	30 Jan 2023	2022	FY
2020	$239,088	+$103,094	+76%	01 Nov 2019	31 Oct 2020	10-K	11 Feb 2022	2021	FY
2019	$135,994	-$2,649,531	-95%	01 Nov 2018	31 Oct 2019	10-K	01 Feb 2021	2020	FY
2018	$2,785,525	+$2,781,659	+71952%	01 Nov 2017	31 Oct 2018	10-K	29 Jan 2020	2019	FY
2017	$3,866	-$48,968	-93%	01 Nov 2016	31 Oct 2017	10-K	29 Jan 2019	2018	FY
2016	$52,834	-$115,148	-69%	01 Nov 2015	31 Oct 2016	10-K	29 Jan 2018	2017	FY
2015	$167,982	-$296,545	-64%	01 Nov 2014	31 Oct 2015	10-K	31 Jan 2017	2016	FY
2014	$464,527	-$705,294	-60%	01 Nov 2013	31 Oct 2014	10-K	29 Jan 2016	2015	FY
2013	$1,169,821	+$101,215	+9.5%	01 Nov 2012	31 Oct 2013	10-K	29 Jan 2015	2014	FY
2012	$1,068,606	+$763,809	+251%	01 Nov 2011	31 Oct 2012	10-K	29 Jan 2014	2013	FY
2011	$304,797	+$55,521	+22%	01 Nov 2010	31 Oct 2011	10-K	29 Jan 2013	2012	FY
2010	$249,276			01 Nov 2009	31 Oct 2010	10-K/A	31 Jan 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.